Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Lupus Nephritis, or a Mimic?

Matthew J. Mandell, DO, FACP, Yishui Chen, MD, Prerna Rastogi, MD, PhD, & Rebecca Tuetken, MD, PhD  |  May 31, 2025

Initial urinalysis several weeks prior to admission showed 2–3+ protein, 2+ blood, and no casts. Proteinuria was quantified with random urine-to-protein-creatinine ratio, which was elevated at 5.65 g/g Cr. The ANA titer was 1:640 in nuclear coarse speckled pattern; tests for anti-Smith and double-stranded DNA antibodies were negative.

Serum complements were not low. A test for phospholipase A2 receptor (PLA2R) antibody was negative. Tests for human immunodeficiency virus (HIV) antigen and antibody, hepatitis B surface antigen and antibody, and hepatitis C antibody were negative. A test for RPR was positive (1:256), with a positive confirmatory syphilis total antibody test. Chlamydia and gonorrhea polymerase chain reaction testing returned negative. Tests for anti-phospholipid antibodies were negative.

Figure 3: Immunofluorescence C1q Stain. Trace staining also noted for C1q in similar distribution as IgG stain. (Click to enlarge.)

The complete blood count test with differential was normal. Ferritin (408 ng/mL; RR: 12–300 ng/ mL for men) and erythrocyte sedimentation rate (ESR) (56 mm/ Hr; RR: 0–15 mm/Hr) were elevated; C-reactive protein (CRP) was just above the upper limit of normal (0.6 mg/dL; RR: <0.5 mg/dL).

Liver function tests revealed hypoalbuminemia (1.9 g/dL) and elevated alkaline phosphatase (413 U/L; RR: <129 U/L) and gamma-glutamyl transferase (872 U/L; RR: <61 U/L). Serum parvovirus B19 IgG (1.16 IV; RR: <0.90 IV) and IgM (1.97 IV; RR: <0.90 IV) were consistent with recently acquired infection.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A renal biopsy was suggestive of classes II and V lupus nephritis; however, no crescents were identified (see Figure 1). Renal biopsy showed a combined (segmental) membranous and minimal mesangial pattern of glomerulonephritis with negative PLA2R antibody stain (see Figure 2). On immunofluorescence, glomeruli showed segmental, capillary loop and full-house pattern (positive for IgG, IgM, IgA, C3, C1q) co-staining (see Figures 3 and 4). Spirochete stain was negative on immunohistochemistry.

Figure 4: Electron Microscopy. Rare subepithelial and mesangial immune complex mediated type electron dense deposits present. Moderate podocyte epithelial foot process effacement. (Click to enlarge.)

Given the presence of persistent headache, along with neck tenderness and positive syphilis testing, a lumbar puncture with cerebrospinal fluid analysis was performed, which revealed normal cell count, negative gram stain, normal glucose and negative venereal disease research laboratory test.

Patient presented with nephrotic syndrome (i.e., nephrotic range: proteinuria, elevated cholesterol and edema), which improved during his hospitalization. He was treated with 30 mg of lisinopril daily and 40 mg of atorvastatin daily.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportLupus nephritis supplementparvovirus B19syphilis

Related Articles

    Case Report: Lupus Nephritis or a Mimic?

    November 10, 2022

    Syphilis, an ancient disease caused by the spirochete Treponema pallidum, has been historically referred to as the great mimicker given its heterogenous presentation. Both systemic lupus erythematosus (SLE) and syphilis can have multi-systemic involve­ment. Both parvovirus B19 and syphilis have been reported to cause histologic features similar to those seen in lupus nephritis.  We present…

    A Case of Lupus Podocytopathy

    June 17, 2024

    Kidney involvement is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Collectively termed lupus nephritis, SLE with kidney involvement comes in many subtypes. The current classification by the International Society of Nephrology/Renal Pathology Society (ISN/RPS), however, does not include lupus podocytopathy, which, through various clinical and epidemiologic studies, has recently been…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Tacrolimus Use for Lupus Nephritis Raises Debate over Role in North American Population

    October 10, 2016

    The following summary regarding use of tacrolimus (TAC) in lupus nephritis highlights a number of debatable points. Although the role of TAC in lupus nephritis remains unproved for North American populations, it might be an excellent option in some clinical situations. These situations include lupus flare during pregnancy and also for lupus nephritis when the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences